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Learning Objectives
===================

Upon completion of this activity, participants will be able to:

-   Describe the impact of HIV infection on malaria infection

-   Identify different levels of severity of malaria infection

-   Describe the presentation of severe malaria in patients infected with HIV-1 in one region in Zambia

-   Compare the risk for severe malaria in relation to CD4 count in patients infected with HIV-1
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CME Questions
=============

1.  Which of the following best explains the large scale of the HIV-1--malaria interaction that has emerged in the last decade?

    1.  A. Longer survival of patients infected with HIV

    2.  B. Effects of increased antiretroviral drug use

    3.  C. Poor immune function and higher susceptibility

    4.  D. Poor control of malaria worldwide

2.  **A 28-year-old Zambian patient presents with a fever of 38.5°C,** ***P**lasmodiumfalciparum* on thick smear with 120 parasites per 200 white blood cells, and jaundice. Which of the following best describes the likely diagnosis?**

    1.  A. Uncomplicated malaria

    2.  B. Moderately severe malaria

    3.  C. Severe malaria

    4.  D. HIV and malaria

3.  The study noted the importance of fever as an indicator of severe malaria in patients infected with HIV-1. Which of the following features were most commonly encountered in addition to fever?

    1.  A. Impaired consciousness and jaundice

    2.  B. Impaired consciousness and hypoglycemia

    3.  C. Multiple convulsions and jaundice

    4.  D. Hypoglycemia and jaundice

4.  Which of the following best describes the association between HIV-1 infection and risk for severe malaria in the population studied?

    1.  A. HIV-1 infection is a risk factor for uncomplicated and severe malaria

    2.  B. Risk for severe malaria is only increased in patients with HIV-1 with a CD4 count \<250 cells/µL

    3.  C. HIV-1 infection increases the risk for severe malaria

    4.  D. Risk for severe malaria is increased only in patients with AIDS
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